ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Neumora Therapeutics Inc

Neumora Therapeutics Inc (NMRA)

12.92
0.19
(1.49%)
Closed September 20 3:00PM
12.92
0.00
(0.00%)
After Hours: 5:56PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
12.92
Bid
10.72
Ask
14.40
Volume
6,167,143
12.45 Day's Range 13.21
8.33 52 Week Range 21.00
Market Cap
Previous Close
12.73
Open
12.81
Last Trade Time
Financial Volume
US$ 79,125,826
VWAP
12.8302
Average Volume (3m)
780,090
Shares Outstanding
160,027,746
Dividend Yield
-
PE Ratio
-8.76
Earnings Per Share (EPS)
-1.47
Revenue
-
Net Profit
-235.93M

About Neumora Therapeutics Inc

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, ... Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
New Castle, Delaware, USA
Founded
-
Neumora Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker NMRA. The last closing price for Neumora Therapeutics was US$12.73. Over the last year, Neumora Therapeutics shares have traded in a share price range of US$ 8.33 to US$ 21.00.

Neumora Therapeutics currently has 160,027,746 shares outstanding. The market capitalization of Neumora Therapeutics is US$2.04 billion. Neumora Therapeutics has a price to earnings ratio (PE ratio) of -8.76.

NMRA Latest News

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders

WATERTOWN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.927.666666666671213.5211.668505212.10910633CS
41.4212.34782608711.513.5210.3551228411.62209615CS
123.6939.97833152769.2313.529.13578009011.08229171CS
26-1.06-7.5822603719613.9814.958.3369448110.91121884CS
520.120.937512.8218.3352189311.95508303CS
156-3.58-21.69696969716.5218.3353003212.0295252CS
260-3.58-21.69696969716.5218.3353003212.0295252CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BNZIBanzai International Inc
US$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
US$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
US$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
US$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
US$ 1.34
(-82.89%)
26.41M
CRBPCorbus Pharmaceuticals Holdings Inc
US$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
US$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
US$ 0.0855
(-42.27%)
15.04M
SKYESkye Bioscience Inc
US$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
US$ 116.00
(-1.59%)
378.15M
AAPLApple Inc
US$ 228.20
(-0.29%)
320.24M
INTCIntel Corporation
US$ 21.84
(3.31%)
261.64M
VERBVerb Technology Company Inc
US$ 0.0742
(33.45%)
178.64M

Your Recent History

Delayed Upgrade Clock